| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Fusion | 18 | 2021 | 146 | 2.230 |
Why?
|
| Lumbar Vertebrae | 15 | 2021 | 157 | 2.190 |
Why?
|
| Cervical Vertebrae | 13 | 2012 | 109 | 1.700 |
Why?
|
| Deep Brain Stimulation | 5 | 2013 | 66 | 1.220 |
Why?
|
| Philosophy | 2 | 2020 | 12 | 1.160 |
Why?
|
| Vertebral Artery | 4 | 2011 | 28 | 1.120 |
Why?
|
| Rivers | 3 | 2017 | 21 | 1.000 |
Why?
|
| Bone Screws | 7 | 2007 | 30 | 0.940 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2024 | 125 | 0.910 |
Why?
|
| Knee Prosthesis | 2 | 2024 | 10 | 0.910 |
Why?
|
| Kleine-Levin Syndrome | 1 | 2024 | 1 | 0.880 |
Why?
|
| Benzofurans | 1 | 2024 | 11 | 0.870 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2024 | 5 | 0.870 |
Why?
|
| Food Chain | 2 | 2015 | 2 | 0.870 |
Why?
|
| Melatonin | 1 | 2024 | 66 | 0.860 |
Why?
|
| Cyclopropanes | 1 | 2024 | 50 | 0.850 |
Why?
|
| Sleep | 2 | 2024 | 224 | 0.850 |
Why?
|
| Airports | 1 | 2023 | 1 | 0.850 |
Why?
|
| Sleep Wake Disorders | 1 | 2024 | 69 | 0.800 |
Why?
|
| Religion | 1 | 2020 | 30 | 0.680 |
Why?
|
| Thoracic Vertebrae | 5 | 2013 | 33 | 0.630 |
Why?
|
| Spondylolisthesis | 4 | 2014 | 42 | 0.620 |
Why?
|
| Invertebrates | 2 | 2015 | 21 | 0.560 |
Why?
|
| Eye Movements | 2 | 2016 | 83 | 0.540 |
Why?
|
| Memory, Short-Term | 1 | 2016 | 60 | 0.490 |
Why?
|
| Intervertebral Disc | 3 | 2010 | 16 | 0.480 |
Why?
|
| Subthalamic Nucleus | 2 | 2012 | 14 | 0.480 |
Why?
|
| Electroencephalography | 1 | 2016 | 149 | 0.480 |
Why?
|
| Decompression, Surgical | 3 | 2018 | 66 | 0.470 |
Why?
|
| Knowledge | 1 | 2015 | 31 | 0.460 |
Why?
|
| Fishes | 1 | 2015 | 20 | 0.460 |
Why?
|
| Sacrum | 3 | 2011 | 27 | 0.460 |
Why?
|
| Spinal Stenosis | 2 | 2012 | 26 | 0.450 |
Why?
|
| Humans | 56 | 2024 | 63152 | 0.450 |
Why?
|
| Dystonic Disorders | 2 | 2013 | 8 | 0.450 |
Why?
|
| Cyanoacrylates | 1 | 2014 | 1 | 0.440 |
Why?
|
| Cerebral Ventriculitis | 1 | 2014 | 2 | 0.440 |
Why?
|
| Cochlear Implantation | 2 | 2024 | 28 | 0.440 |
Why?
|
| Cerebral Ventricles | 1 | 2014 | 29 | 0.430 |
Why?
|
| Postoperative Complications | 8 | 2021 | 1293 | 0.430 |
Why?
|
| Electromagnetic Fields | 2 | 2003 | 14 | 0.420 |
Why?
|
| Catheters, Indwelling | 1 | 2014 | 69 | 0.420 |
Why?
|
| Globus Pallidus | 1 | 2013 | 25 | 0.420 |
Why?
|
| Tremor | 1 | 2013 | 24 | 0.410 |
Why?
|
| Oncorhynchus mykiss | 1 | 2013 | 2 | 0.410 |
Why?
|
| Salmon | 1 | 2013 | 8 | 0.410 |
Why?
|
| Internal Fixators | 3 | 2007 | 10 | 0.400 |
Why?
|
| Neurosurgery | 3 | 2012 | 29 | 0.370 |
Why?
|
| Fibula | 1 | 2010 | 9 | 0.340 |
Why?
|
| Spinal Diseases | 3 | 2019 | 48 | 0.340 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2018 | 2159 | 0.340 |
Why?
|
| Neurosurgical Procedures | 3 | 2011 | 99 | 0.340 |
Why?
|
| Adult | 21 | 2024 | 16736 | 0.330 |
Why?
|
| Male | 28 | 2024 | 29717 | 0.330 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2003 | 658 | 0.320 |
Why?
|
| Reoperation | 5 | 2024 | 290 | 0.320 |
Why?
|
| Movement Disorders | 1 | 2009 | 23 | 0.310 |
Why?
|
| Intraoperative Care | 3 | 2024 | 38 | 0.300 |
Why?
|
| Retrospective Studies | 11 | 2024 | 6595 | 0.300 |
Why?
|
| Prosthesis Failure | 2 | 2023 | 73 | 0.290 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 143 | 0.290 |
Why?
|
| Cadaver | 6 | 2007 | 125 | 0.280 |
Why?
|
| Brain | 1 | 2016 | 1553 | 0.280 |
Why?
|
| Joint Dislocations | 2 | 2001 | 17 | 0.280 |
Why?
|
| Safety Management | 1 | 2009 | 137 | 0.280 |
Why?
|
| Radiography | 9 | 2011 | 540 | 0.270 |
Why?
|
| Medical Errors | 1 | 2009 | 195 | 0.260 |
Why?
|
| Intraoperative Complications | 3 | 2009 | 90 | 0.260 |
Why?
|
| Female | 28 | 2024 | 32709 | 0.240 |
Why?
|
| Treatment Outcome | 13 | 2024 | 5625 | 0.230 |
Why?
|
| Patellofemoral Joint | 1 | 2024 | 6 | 0.220 |
Why?
|
| Receptors, Melatonin | 1 | 2024 | 34 | 0.220 |
Why?
|
| Delphi Technique | 1 | 2024 | 97 | 0.220 |
Why?
|
| Aged | 14 | 2024 | 14333 | 0.210 |
Why?
|
| Spinal Cord | 2 | 2012 | 204 | 0.210 |
Why?
|
| Adolescent | 9 | 2013 | 6229 | 0.210 |
Why?
|
| Diskectomy | 2 | 2001 | 36 | 0.200 |
Why?
|
| Consensus | 1 | 2024 | 228 | 0.200 |
Why?
|
| Middle Aged | 15 | 2024 | 17480 | 0.200 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 1606 | 0.200 |
Why?
|
| Time Factors | 9 | 2011 | 3754 | 0.190 |
Why?
|
| Risk Assessment | 4 | 2021 | 2066 | 0.190 |
Why?
|
| Parkinson Disease | 3 | 2012 | 130 | 0.190 |
Why?
|
| Airway Obstruction | 1 | 2002 | 38 | 0.190 |
Why?
|
| Chi-Square Distribution | 3 | 2012 | 417 | 0.190 |
Why?
|
| Spine | 1 | 2002 | 48 | 0.190 |
Why?
|
| Intervertebral Disc Displacement | 2 | 2001 | 17 | 0.180 |
Why?
|
| Recurrent Laryngeal Nerve Injuries | 1 | 2001 | 5 | 0.180 |
Why?
|
| Orthopedic Procedures | 2 | 2013 | 50 | 0.180 |
Why?
|
| Axis, Cervical Vertebra | 1 | 2001 | 4 | 0.180 |
Why?
|
| Cervical Atlas | 1 | 2001 | 3 | 0.180 |
Why?
|
| Knee Joint | 1 | 2023 | 291 | 0.180 |
Why?
|
| Spinal Injuries | 1 | 2001 | 12 | 0.180 |
Why?
|
| Robotic Surgical Procedures | 1 | 2024 | 152 | 0.180 |
Why?
|
| Gravitation | 1 | 2020 | 10 | 0.180 |
Why?
|
| Phenylalanine | 1 | 2021 | 26 | 0.180 |
Why?
|
| Spinal Osteophytosis | 2 | 2001 | 3 | 0.170 |
Why?
|
| Low Back Pain | 2 | 2007 | 114 | 0.170 |
Why?
|
| Bone Plates | 2 | 2001 | 31 | 0.170 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2021 | 59 | 0.170 |
Why?
|
| Integrins | 1 | 2021 | 108 | 0.170 |
Why?
|
| Age Distribution | 3 | 2011 | 259 | 0.170 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2024 | 713 | 0.170 |
Why?
|
| Athletic Injuries | 1 | 2001 | 83 | 0.170 |
Why?
|
| Circadian Rhythm | 1 | 2024 | 382 | 0.170 |
Why?
|
| Sports | 1 | 2001 | 96 | 0.170 |
Why?
|
| Accidents, Traffic | 1 | 2001 | 146 | 0.160 |
Why?
|
| Motion Perception | 2 | 2009 | 5 | 0.160 |
Why?
|
| Recovery of Function | 3 | 2018 | 286 | 0.160 |
Why?
|
| Analysis of Variance | 3 | 2007 | 608 | 0.160 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 1645 | 0.160 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 209 | 0.150 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 1999 | 61 | 0.150 |
Why?
|
| Osteoarthritis, Knee | 1 | 2024 | 385 | 0.150 |
Why?
|
| Braces | 1 | 1998 | 10 | 0.150 |
Why?
|
| Risk Factors | 8 | 2019 | 5331 | 0.150 |
Why?
|
| Central Cord Syndrome | 1 | 2018 | 2 | 0.150 |
Why?
|
| Drainage | 2 | 2014 | 154 | 0.150 |
Why?
|
| Child | 6 | 2011 | 4520 | 0.140 |
Why?
|
| Photorefractive Keratectomy | 3 | 2006 | 3 | 0.140 |
Why?
|
| Reaction Time | 2 | 2016 | 124 | 0.140 |
Why?
|
| Random Allocation | 3 | 2003 | 199 | 0.140 |
Why?
|
| Venous Thromboembolism | 1 | 2019 | 149 | 0.140 |
Why?
|
| Biophysical Phenomena | 1 | 2017 | 23 | 0.140 |
Why?
|
| Bone Transplantation | 2 | 2011 | 29 | 0.140 |
Why?
|
| Intracranial Aneurysm | 1 | 2002 | 365 | 0.140 |
Why?
|
| Intervertebral Disc Degeneration | 2 | 2014 | 16 | 0.130 |
Why?
|
| Thoracoscopes | 1 | 1996 | 2 | 0.130 |
Why?
|
| Endoscopes | 1 | 1996 | 7 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2017 | 48 | 0.130 |
Why?
|
| Conservation of Natural Resources | 1 | 2017 | 39 | 0.130 |
Why?
|
| Osteosarcoma | 1 | 2017 | 58 | 0.130 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2016 | 12 | 0.130 |
Why?
|
| Saccades | 1 | 2016 | 15 | 0.130 |
Why?
|
| Quality of Life | 1 | 2023 | 1223 | 0.130 |
Why?
|
| Vision, Ocular | 1 | 2016 | 20 | 0.130 |
Why?
|
| AIDS-Related Opportunistic Infections | 3 | 2001 | 68 | 0.130 |
Why?
|
| Fixation, Ocular | 1 | 2016 | 33 | 0.130 |
Why?
|
| Evoked Potentials | 1 | 2016 | 39 | 0.130 |
Why?
|
| Spinal Fractures | 2 | 1993 | 36 | 0.120 |
Why?
|
| Animals | 11 | 2021 | 20610 | 0.120 |
Why?
|
| Spinal Cord Compression | 2 | 2009 | 29 | 0.120 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 125 | 0.120 |
Why?
|
| Essential Tremor | 2 | 2012 | 18 | 0.120 |
Why?
|
| Scoliosis | 1 | 1995 | 9 | 0.120 |
Why?
|
| History, 17th Century | 1 | 2015 | 6 | 0.120 |
Why?
|
| Biomechanical Phenomena | 3 | 2010 | 268 | 0.120 |
Why?
|
| History, 18th Century | 1 | 2015 | 9 | 0.120 |
Why?
|
| England | 1 | 2015 | 29 | 0.120 |
Why?
|
| Brain Mapping | 1 | 2016 | 232 | 0.120 |
Why?
|
| Monitoring, Intraoperative | 2 | 2012 | 46 | 0.120 |
Why?
|
| Washington | 1 | 2015 | 26 | 0.120 |
Why?
|
| Predictive Value of Tests | 4 | 2013 | 1082 | 0.110 |
Why?
|
| Biodiversity | 1 | 2015 | 38 | 0.110 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 102 | 0.110 |
Why?
|
| Single-Blind Method | 2 | 2011 | 143 | 0.110 |
Why?
|
| Follow-Up Studies | 5 | 2011 | 2451 | 0.110 |
Why?
|
| Decision Making | 3 | 2009 | 407 | 0.110 |
Why?
|
| Cornea | 3 | 2001 | 24 | 0.110 |
Why?
|
| Fluoroscopy | 2 | 2003 | 64 | 0.100 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 123 | 0.100 |
Why?
|
| Incidence | 2 | 2011 | 1372 | 0.100 |
Why?
|
| Intubation, Intratracheal | 2 | 2008 | 204 | 0.100 |
Why?
|
| Aged, 80 and over | 5 | 2010 | 5429 | 0.100 |
Why?
|
| Laminectomy | 2 | 2018 | 21 | 0.100 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2003 | 58 | 0.100 |
Why?
|
| Electrodes, Implanted | 2 | 2012 | 37 | 0.100 |
Why?
|
| Biomass | 1 | 2013 | 28 | 0.100 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 2012 | 9 | 0.100 |
Why?
|
| Reproduction | 1 | 2013 | 92 | 0.100 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2013 | 70 | 0.100 |
Why?
|
| Electrodes | 1 | 2012 | 36 | 0.100 |
Why?
|
| Radiation Dosage | 1 | 2013 | 132 | 0.090 |
Why?
|
| Spinal Cord Injuries | 1 | 2012 | 50 | 0.090 |
Why?
|
| Transplantation, Homologous | 2 | 2010 | 243 | 0.090 |
Why?
|
| Functional Laterality | 1 | 2012 | 138 | 0.090 |
Why?
|
| Thalamus | 1 | 2012 | 72 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2012 | 286 | 0.090 |
Why?
|
| Checklist | 1 | 2012 | 73 | 0.090 |
Why?
|
| Brain Injuries | 1 | 2013 | 139 | 0.090 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 158 | 0.090 |
Why?
|
| Oligopeptides | 1 | 2011 | 132 | 0.090 |
Why?
|
| Tibia | 1 | 2011 | 70 | 0.090 |
Why?
|
| Histoplasmosis | 2 | 2001 | 24 | 0.090 |
Why?
|
| Polyethylene | 1 | 2010 | 10 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2013 | 259 | 0.090 |
Why?
|
| Brain Diseases | 1 | 2011 | 76 | 0.090 |
Why?
|
| Arthroplasty, Replacement | 1 | 2010 | 17 | 0.090 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 168 | 0.080 |
Why?
|
| Sex Distribution | 2 | 2002 | 253 | 0.080 |
Why?
|
| Antifungal Agents | 2 | 2001 | 127 | 0.080 |
Why?
|
| Scattering, Radiation | 4 | 2013 | 73 | 0.080 |
Why?
|
| Temporal Lobe | 1 | 2009 | 45 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2012 | 1004 | 0.080 |
Why?
|
| Models, Neurological | 1 | 2009 | 80 | 0.080 |
Why?
|
| Macaca mulatta | 3 | 2021 | 250 | 0.080 |
Why?
|
| Spondylosis | 1 | 2009 | 26 | 0.070 |
Why?
|
| Association Learning | 1 | 2008 | 8 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 1143 | 0.070 |
Why?
|
| Surveys and Questionnaires | 3 | 2024 | 2673 | 0.070 |
Why?
|
| Learning | 1 | 2009 | 181 | 0.070 |
Why?
|
| Prosthesis Design | 2 | 2024 | 225 | 0.070 |
Why?
|
| Swine | 2 | 1999 | 370 | 0.070 |
Why?
|
| Dissection | 1 | 2007 | 48 | 0.070 |
Why?
|
| Corneal Opacity | 1 | 2006 | 4 | 0.070 |
Why?
|
| Corneal Stroma | 1 | 2006 | 9 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2009 | 564 | 0.070 |
Why?
|
| Range of Motion, Articular | 1 | 2007 | 100 | 0.060 |
Why?
|
| Stress, Mechanical | 2 | 2010 | 112 | 0.060 |
Why?
|
| Algorithms | 2 | 2009 | 1001 | 0.060 |
Why?
|
| United States | 3 | 2017 | 7827 | 0.060 |
Why?
|
| Intraoperative Period | 2 | 2002 | 33 | 0.060 |
Why?
|
| Hearing Tests | 1 | 2024 | 4 | 0.060 |
Why?
|
| Rabbits | 3 | 2006 | 332 | 0.060 |
Why?
|
| Young Adult | 2 | 2012 | 4673 | 0.060 |
Why?
|
| Cochlear Implants | 1 | 2024 | 31 | 0.060 |
Why?
|
| Itraconazole | 2 | 2001 | 13 | 0.050 |
Why?
|
| Prevalence | 2 | 1999 | 1375 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2010 | 3270 | 0.050 |
Why?
|
| Fracture Fixation, Internal | 2 | 1993 | 59 | 0.050 |
Why?
|
| Blood Loss, Surgical | 1 | 2002 | 62 | 0.050 |
Why?
|
| Neck | 1 | 2002 | 46 | 0.050 |
Why?
|
| Tracheostomy | 1 | 2002 | 36 | 0.050 |
Why?
|
| Drug Resistance, Fungal | 1 | 2001 | 10 | 0.050 |
Why?
|
| Fluconazole | 1 | 2001 | 13 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 1176 | 0.050 |
Why?
|
| Physicians | 2 | 2012 | 471 | 0.050 |
Why?
|
| Prognosis | 2 | 2012 | 1741 | 0.050 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2001 | 4 | 0.050 |
Why?
|
| Vocal Cord Paralysis | 1 | 2001 | 10 | 0.050 |
Why?
|
| Radiculopathy | 1 | 2001 | 20 | 0.040 |
Why?
|
| Intracranial Thrombosis | 1 | 2001 | 28 | 0.040 |
Why?
|
| Professional Practice | 1 | 2001 | 24 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2001 | 54 | 0.040 |
Why?
|
| Traction | 1 | 2001 | 5 | 0.040 |
Why?
|
| Cerebral Veins | 1 | 2001 | 36 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2021 | 22 | 0.040 |
Why?
|
| Corneal Diseases | 1 | 2001 | 4 | 0.040 |
Why?
|
| Alkylating Agents | 1 | 2001 | 8 | 0.040 |
Why?
|
| Lymphoid Tissue | 1 | 2021 | 55 | 0.040 |
Why?
|
| Mitomycin | 1 | 2001 | 26 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2001 | 138 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2001 | 137 | 0.040 |
Why?
|
| Specialization | 1 | 2001 | 81 | 0.040 |
Why?
|
| Medicine | 1 | 2001 | 57 | 0.040 |
Why?
|
| Cicatrix | 1 | 2001 | 61 | 0.040 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2002 | 108 | 0.040 |
Why?
|
| Orthopedics | 1 | 2000 | 32 | 0.040 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2021 | 79 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2002 | 310 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 2000 | 46 | 0.040 |
Why?
|
| Candidiasis | 1 | 2000 | 51 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2024 | 590 | 0.040 |
Why?
|
| Candida albicans | 1 | 2000 | 72 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2000 | 115 | 0.040 |
Why?
|
| Preoperative Care | 2 | 2012 | 191 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 1999 | 104 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2000 | 108 | 0.040 |
Why?
|
| Vena Cava Filters | 1 | 2019 | 23 | 0.040 |
Why?
|
| Virus Replication | 1 | 2021 | 319 | 0.040 |
Why?
|
| New York | 1 | 1999 | 144 | 0.040 |
Why?
|
| Comorbidity | 1 | 2002 | 1118 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2019 | 122 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2002 | 863 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 2018 | 53 | 0.040 |
Why?
|
| Lasers, Excimer | 3 | 2006 | 3 | 0.040 |
Why?
|
| Postoperative Care | 1 | 1998 | 123 | 0.040 |
Why?
|
| Geography | 1 | 2017 | 38 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 60 | 0.030 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 111 | 0.030 |
Why?
|
| Smoking | 1 | 2002 | 864 | 0.030 |
Why?
|
| Psychometrics | 2 | 2009 | 375 | 0.030 |
Why?
|
| Ecosystem | 1 | 2017 | 53 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2001 | 734 | 0.030 |
Why?
|
| Light | 3 | 2006 | 202 | 0.030 |
Why?
|
| Photometry | 1 | 1996 | 7 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 189 | 0.030 |
Why?
|
| Curriculum | 1 | 2000 | 591 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 201 | 0.030 |
Why?
|
| Video Recording | 1 | 1996 | 134 | 0.030 |
Why?
|
| Refractive Errors | 1 | 1996 | 12 | 0.030 |
Why?
|
| Mass Screening | 1 | 2002 | 688 | 0.030 |
Why?
|
| Deglutition Disorders | 1 | 1996 | 42 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2017 | 206 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 490 | 0.030 |
Why?
|
| Body Height | 1 | 1995 | 68 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 450 | 0.030 |
Why?
|
| Linear Models | 1 | 1995 | 408 | 0.030 |
Why?
|
| Body Weight | 1 | 1995 | 377 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 1995 | 291 | 0.030 |
Why?
|
| Thermoluminescent Dosimetry | 1 | 2013 | 3 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2013 | 14 | 0.030 |
Why?
|
| Body Size | 1 | 2013 | 24 | 0.030 |
Why?
|
| Africa, Northern | 1 | 2012 | 1 | 0.030 |
Why?
|
| South Africa | 1 | 2012 | 14 | 0.030 |
Why?
|
| Titanium | 1 | 1993 | 60 | 0.020 |
Why?
|
| Japan | 1 | 2012 | 59 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 1461 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2013 | 64 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 980 | 0.020 |
Why?
|
| Paralysis | 1 | 2012 | 17 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2000 | 800 | 0.020 |
Why?
|
| Rotation | 1 | 2012 | 22 | 0.020 |
Why?
|
| Evoked Potentials, Motor | 1 | 2012 | 21 | 0.020 |
Why?
|
| Spinal Nerve Roots | 1 | 2012 | 18 | 0.020 |
Why?
|
| Australia | 1 | 2012 | 120 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 1543 | 0.020 |
Why?
|
| Europe | 1 | 2012 | 194 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 1995 | 1121 | 0.020 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2011 | 1 | 0.020 |
Why?
|
| Osseointegration | 1 | 2011 | 5 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2008 | 308 | 0.020 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2011 | 15 | 0.020 |
Why?
|
| Dura Mater | 1 | 2011 | 34 | 0.020 |
Why?
|
| Equipment Design | 1 | 2013 | 345 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2011 | 165 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2011 | 99 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 115 | 0.020 |
Why?
|
| Device Removal | 1 | 2010 | 65 | 0.020 |
Why?
|
| Motivation | 1 | 2012 | 285 | 0.020 |
Why?
|
| Microelectrodes | 1 | 2009 | 14 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2009 | 25 | 0.020 |
Why?
|
| Recurrence | 2 | 2001 | 639 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2179 | 0.020 |
Why?
|
| Lateral Medullary Syndrome | 1 | 2009 | 2 | 0.020 |
Why?
|
| Rhombencephalon | 1 | 2009 | 7 | 0.020 |
Why?
|
| Postoperative Hemorrhage | 1 | 2009 | 38 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 60 | 0.020 |
Why?
|
| Evoked Potentials, Visual | 1 | 2008 | 13 | 0.020 |
Why?
|
| Visual Fields | 1 | 2008 | 49 | 0.020 |
Why?
|
| Registries | 1 | 2012 | 886 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2008 | 90 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2008 | 64 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2008 | 140 | 0.020 |
Why?
|
| Steroids | 1 | 2008 | 55 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2009 | 180 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 391 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2009 | 290 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2008 | 230 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 2560 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 234 | 0.020 |
Why?
|
| Histoplasma | 1 | 2001 | 16 | 0.010 |
Why?
|
| Protein C Deficiency | 1 | 2001 | 2 | 0.010 |
Why?
|
| Antithrombin III Deficiency | 1 | 2001 | 2 | 0.010 |
Why?
|
| Mastoiditis | 1 | 2001 | 2 | 0.010 |
Why?
|
| Pseudarthrosis | 1 | 2001 | 1 | 0.010 |
Why?
|
| Dehydration | 1 | 2001 | 17 | 0.010 |
Why?
|
| Equipment Failure | 1 | 2001 | 65 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2001 | 199 | 0.010 |
Why?
|
| Ophthalmic Solutions | 1 | 2001 | 7 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2001 | 165 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 2001 | 83 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2001 | 203 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 2001 | 96 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2001 | 97 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2001 | 102 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2001 | 96 | 0.010 |
Why?
|
| Shock | 1 | 2000 | 33 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2000 | 105 | 0.010 |
Why?
|
| Physical Examination | 1 | 2000 | 112 | 0.010 |
Why?
|
| Patient Care | 1 | 2000 | 80 | 0.010 |
Why?
|
| Wound Healing | 1 | 2001 | 189 | 0.010 |
Why?
|
| Research | 1 | 2000 | 193 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2000 | 198 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2000 | 155 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2001 | 1355 | 0.010 |
Why?
|
| Birefringence | 1 | 1996 | 1 | 0.010 |
Why?
|
| Infant | 1 | 2001 | 1649 | 0.010 |
Why?
|
| Refractive Surgical Procedures | 1 | 1996 | 1 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2001 | 1988 | 0.010 |
Why?
|
| Ophthalmology | 1 | 1996 | 24 | 0.010 |
Why?
|
| Visual Acuity | 1 | 1996 | 125 | 0.010 |
Why?
|